Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

The company offers year-round educational services on the conditions, using this month, in particular, to guide patients to ...

The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...

Collaboration between TLI and AMDF underscores a shared commitment to making a meaningful difference in the lives of those affected by AMD. Together, TLI and AMDF are dedicated to advancing awareness, ...

Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

But in many cases, it can certainly help with vision problems, SaveHealth reports. Conditions like glaucoma, macular degeneration, and corneal abrasions sometimes require medications to cure the ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...